Patent AnalyticsExaminers
Rankings

Company or institution

EXELIXIS, INC.

279 applicationsfiled 2006 to 2026

Allowance rate
58%
−18 pts vs the USPTO range 52% to 64%
Rejections before allowance
1.6
level with the USPTO
Months to first action
14.6 mo
−4.0 vs the USPTO
Needed an RCE
33%
+6 pts vs the USPTO

Timeline

Applications by filing year: drag across the years to study a period

Allowed in green, abandoned in red, pending in grey. The figures above and the charts that can be recomputed by filing year follow the span you pick.

Compared with the office

Against every applicant before the USPTO

Unlock the comparison with the officeFree with an account. No card needed.

Create a free account

Trend

Allowance by filing year

Unlock the trendIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Domains

Where the applications fall

CPC subclasses

C07D Heterocyclic compounds103 apps
A61K Medical preparations93 apps
G01N Investigating or analysing materials30 apps
A61P Therapeutic activity of compounds17 apps
C12Q Measuring or testing processes involving enzymes or nucleic acids11 apps
C07K Peptides11 apps

Art units

162548 apps
162443 apps
162625 apps
162717 apps
162115 apps
162813 apps

Rejection fingerprint

What gets rejected, by statute

Share of parsed office actions raising each ground; blue is the USPTO.

Unlock the rejection fingerprintIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

What works

Allowance by strategy used

Unlock what works for this filerIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Interviews

Does an interview help?

Unlock the interview figuresFree with an account. No card needed.

Create a free account

Applications

Every application in the record

ApplicationTitleFiledStatusRejectionsRCEsTo 1st action
19513894ILT2 BINDING AGENTS AND USES THEREOF2026-02-24Pending00n/a
19536844Processes for Preparing Quinoline Compounds and Pharmaceutical Compositions Contain…2026-02-11Allowed103.0 mo
19503305ACTIVATABLE TYROSINE-PROTEIN KINASE MEMBRANE RECEPTOR (ROR) ANTIBODY-DRUG CONJUGATE…2026-01-16Pending00n/a
15987727Method and apparatus for adaptive signal processing2012-01-10Allowed1012.0 mo
15763138Composition and method for controlled release2015-02-11Abandoned4123.0 mo
15182358Distributed ledger transaction verification2018-03-12Allowed3020.0 mo
15606409Thermal management of battery assemblies2021-04-13Pending2117.0 mo
15805293Machine learning model for anomaly detection2012-05-14Allowed1014.0 mo
15870838Wireless power transfer coil arrangement2015-06-15Abandoned4125.0 mo
15739557Catalyst for selective hydrogenation2018-07-16Allowed3022.0 mo
Unlock all 279 applications, each with its full timelineIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in